| |
ASDAS scores
|
x
2
/Z/F
|
p
|
|---|
| |
ASDAS < 1.3 (n = 38)
|
1.3 ≤ ASDAS < 2.1 (n = 38)
|
2.1 ≤ ASDAS ≤ 3.5 (n = 50)
|
ASDAS > 3.5 (n = 60)
|
|---|
|
MSU crystallization (+/-) (n)#
|
|
Left sacroiliac joint
|
8/30
|
6/32
|
16/34
|
27/33
|
11.451
|
0.010
|
|
Right sacroiliac joint
|
3/35
|
4/34
|
11/39
|
36/24
|
43.684
|
<0.001
|
|
Hip joint
|
15/23
|
16/22
|
22/28
|
22/38
|
0.676
|
0.879
|
|
Pubic symphysis
|
11/27
|
13/25
|
18/32
|
21/39
|
0.549
|
0.908
|
|
Volume of MSU crystallization (cm3)$
|
|
Left sacroiliac joint
|
0.21 ± 0.62
|
0.14 ± 0.47
|
0.49 ± 1.34
|
0.23 ± 0.57
|
9.198
|
0.027
|
|
Right sacroiliac joint
|
0.04 ± 0.18
|
0.13 ± 0.52
|
0.35 ± 1.09
|
0.57 ± 1.62
|
34.607
|
<0.001
|
|
Total volume at pelvis
|
2.41 ± 6.51
|
2.69 ± 5.04
|
7.40 ± 11.49
|
4.13 ± 7.77
|
10.517
|
0.015
|
|
Serum uric acid (μmol/L)&
|
321.0 ± 100.4
|
326.2 ± 104.2
|
397.9 ± 109.4
|
382.9 ± 99.8
|
6.322
|
<0.001
|
- Values are given as the numbers or the mean ± standard deviation (Mean±SD)
-
ASDAS Ankylosing Spondylitis Disease Activity Score, MSU monosodium urate
-
#Pearson chi-square (x
2) test
-
$Kruskal-Wallis rank-sum test
- &One-way analysis of variance (ANOVA)
